Literature DB >> 32535841

Diagnostic value of mitral regurgitant jet volume in the assessment of mitral regurgitation severity by general imaging three-dimensional quantification.

Wugang Wang1, Yong Jiang2, Junfang Li1, Kun Gong1, Liang Zhao1, Guozhang Tang1, Yuanyuan Meng1, Zhibin Wang3.   

Abstract

Accurate quantification of mitral regurgitation (MR) severity is critical for appropriate clinical decision making regarding surgical intervention. General imaging three-dimensional quantification (GI3DQ) method allows for direct measurement of mitral regurgitant jet volume (MRJvol) with the help of three-dimensional (3D) color flow Doppler imaging. The aim of this study was to evaluate diagnostic value of MRJvol by GI3DQ for MR grading severity, using the guideline recommended integrated approach as a reference. The study included ninety-seven patients with varying degree of MR, and all MR cases were divided into central MR group (n = 44) and eccentric MR group (n = 53). The MRJvol was measured by GI3DQ. The severity of MR was graded on the basis of recommended integrated approach as mild, moderate, or severe. As assessed by receiver operating characteristic analysis, MRJvol by GI3DQ at a cutoff value of 43.4 ml yielded 76.9% of sensitivity and 86.9% of specificity to differentiate moderate from severe MR in all cases, a cutoff value of 47.5 ml yielded 98.9% of sensitivity and 94.4% of specificity to differentiate moderate from severe MR in central MR, and a cutoff value of 40.7 ml yielded 80.0% of sensitivity and 78.6% of specificity to differentiate moderate from severe MR in eccentric MR. MRJvol measured by GI3DQ could assess MR severity, especially in central MR group, which has higher sensitivity and specificity to differentiate moderate from severe MR.

Entities:  

Keywords:  Echocardiography; General imaging three-dimensional quantification; Mitral regurgitant jet volume; Mitral regurgitation

Mesh:

Year:  2020        PMID: 32535841     DOI: 10.1007/s10554-020-01916-3

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  28 in total

1.  Impact of balloon mitral valvuloplasty on left ventricular rotational deformation: Magnetic Resonance Imaging follow up study.

Authors:  Amir Anwar Samaan; Karim Said; Wafaa El Aroussy; Mohamed Hassan; Soha Romeih; Amr Al Sawy; Mohamed Eid Fawzy; Magdi Yacoub
Journal:  Int J Cardiovasc Imaging       Date:  2020-04-23       Impact factor: 2.357

2.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  J Am Coll Cardiol       Date:  2017-03-15       Impact factor: 24.094

Review 3.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.

Authors:  William A Zoghbi; David Adams; Robert O Bonow; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Rebecca T Hahn; Yuchi Han; Judy Hung; Roberto M Lang; Stephen H Little; Dipan J Shah; Stanton Shernan; Paaladinesh Thavendiranathan; James D Thomas; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2017-03-14       Impact factor: 5.251

4.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

5.  Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation.

Authors:  Francesca Bursi; Maurice Enriquez-Sarano; Vuyisile T Nkomo; Steven J Jacobsen; Susan A Weston; Ryan A Meverden; Véronique L Roger
Journal:  Circulation       Date:  2005-01-17       Impact factor: 29.690

6.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Volkmar Falk; Helmut Baumgartner; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur J Cardiothorac Surg       Date:  2017-10-01       Impact factor: 4.191

7.  Quantification of mitral valve regurgitation by 2D and 3D echocardiography compared with cardiac magnetic resonance a systematic review and meta-analysis.

Authors:  Victor Sköldborg; Per Lav Madsen; Morten Dalsgaard; Jawdat Abdulla
Journal:  Int J Cardiovasc Imaging       Date:  2019-10-29       Impact factor: 2.357

8.  Burden of valvular heart diseases: a population-based study.

Authors:  Vuyisile T Nkomo; Julius M Gardin; Thomas N Skelton; John S Gottdiener; Christopher G Scott; Maurice Enriquez-Sarano
Journal:  Lancet       Date:  2006-09-16       Impact factor: 79.321

9.  Quantitative determinants of the outcome of asymptomatic mitral regurgitation.

Authors:  Maurice Enriquez-Sarano; Jean-François Avierinos; David Messika-Zeitoun; Delphine Detaint; Maryann Capps; Vuyisile Nkomo; Christopher Scott; Hartzell V Schaff; A Jamil Tajik
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

10.  Quantification of mitral regurgitation by general imaging three-dimensional quantification: feasibility and accuracy.

Authors:  Wugang Wang; Qiongwen Lin; Weichun Wu; Yong Jiang; Tingyu Lan; Hao Wang
Journal:  J Am Soc Echocardiogr       Date:  2014-01-14       Impact factor: 5.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.